Insomnia Disorders: Clinical Trials

8 trials for Insomnia Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 not yet recruiting, 2 completed, 1 active not recruiting, 1 recruiting. 3 Not applicable, 2 Phase 1, 1 Phase 2, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable3Active not recruiting 1, Not yet recruiting 1, Recruiting 1
Phase 12Completed 1, Not yet recruiting 1
Phase 21Completed 1
Phase 41Not yet recruiting 1

Follow Insomnia Disorders: new trials by email Literature Review of Insomnia Disorders trials Research Report on Insomnia Disorders

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Internet-Based Cognitive Behavioral Therapy and Physical Activity for Insomnia
Internet-based cognitive behavioral therapy & physical ACtivity for INSOMNIa (iCBT-I-PA), Behavioral: Internet-based cognitive behavioral therapy & physical ACtivity for INSOMNIa (iCBT-I) - Insomnia Disorders, Physical Inactivity
Not applicableNot yet recruitingUppsala County Council, Sweden3552026-09-012026-08-31
Evaluating the Efficacy and Safety of Daridorexant Transition From BZRAs in Insomnia Patients(EASY-TIP)
Daridorexant - Insomnia Disorders
Phase 4Not yet recruitingXuanwu Hospital, Beijing1562026-08-012026-07-29
Efficacy and Accuracy of an AI-Driven Sleep Earbud for Chronic Insomnia
AI-driven Neuromodulation Music (NeuroRhythm), Standard Music (Sham Control) - Insomnia, Insomnia Chronic
Not applicableActive not recruitingThe Chinese University of Hong Kong, Shenzhen252026-07-012026-08-04
Ciwujia Capsules/Compound Ciwujia Granules in the Treatment of Insomnia
Ciwujia Capsules/Compound Ciwujia Granules - Insomnia Disorders
Not yet recruitingHui Zhu400002026-01-012025-12-16
Evaluating the Efficacy and Safety of PROSOMNIA Sleep Therapy™ in Patients With Sleep Deprivation and Chronic Insomnia
PROSOMNIA Sleep Therapy™ (PSTx), Anesthesia-Induced Sleep Therapy, Diprivan (propofol), Astra-Zeneca - Chronic Insomnia, Sleep Deprivation
Phase 1Not yet recruitingNyree Penn1002025-11-012025-05-28
Comparative Efficacy of BRT and CBT-I for Insomnia
Cognitive behavioral therapy for insomnia (CBT-I), Bedtime restriction (BRT) - Insomnia Disorders, Insomnia Disorder
Not applicableRecruitingChristoph Nissen1602025-03-102025-02-17
A Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42847922 in Participants With Insomnia Disorder
Placebo, JNJ-42847922, 5 mg, JNJ-42847922, 10 mg - Insomnia Disorders
Phase 2CompletedJanssen Research & Development, LLC3652017-11-232025-04-29
A Study to Determine the Abuse Potential of Single Oral Doses of Lemborexant Compared to Zolpidem, Suvorexant and Placebo in Healthy, Non-Dependent, Recreational Sedative Users
Zolpidem tablets, Suvorexant tablets, over-encapsulated, Lemborexant tablets - Insomnia Disorders
Phase 1CompletedEisai Inc.392017-04-192020-06-29

Narrower conditions

Sleep Initiation and Maintenance Disorders (8)  ·  Sleep Wake Disorders (2)  ·  Alzheimer Disease (1)  ·  Anxiety Disorders (1)  ·  Cancer Pain (1)  ·  Chronobiology Disorders (1)  ·  Combat Disorders (1)  ·  Depression (1)  ·  Idiopathic Hypersomnia (1)  ·  Motor Activity (1)  ·  Pain (1)  ·  Psychological Well-Being (1)  ·  REM Sleep Behavior Disorder (1)  ·  Sedentary Behavior (1)  ·  Sleep Deprivation (1)

Broader conditions

Dyssomnias (8)  ·  Mental Disorders (8)  ·  Nervous System Diseases (8)  ·  Sleep Disorders, Intrinsic (8)  ·  Sleep Wake Disorders (6)  ·  Neurologic Manifestations (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Signs and Symptoms (3)  ·  Behavior (2)  ·  Behavioral Symptoms (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Dementia (1)  ·  Disorders of Excessive Somnolence (1)  ·  Neurocognitive Disorders (1)

Interventions

Zolpidem (2)  ·  Cognitive Behavioral Therapy (1)  ·  Electroencephalography (1)  ·  Exercise (1)  ·  Propofol (1)  ·  Siberian ginseng root (1)  ·  daridorexant (1)  ·  lemborexant (1)  ·  seltorexant (1)  ·  suvorexant (1)

Sponsors

Christoph Nissen (1)  ·  Eisai Inc. (1)  ·  Hui Zhu (1)  ·  Janssen Research & Development, LLC (1)  ·  Nyree Penn (1)  ·  The Chinese University of Hong Kong, Shenzhen (1)  ·  Uppsala County Council, Sweden (1)  ·  Xuanwu Hospital, Beijing (1)

Countries

China (2)  ·  United States (2)  ·  Belgium (1)  ·  Canada (1)  ·  France (1)  ·  Germany (1)  ·  Japan (1)  ·  Poland (1)  ·  Sweden (1)  ·  Switzerland (1)

Top investigators

Alice KY Siu, MMed, FRCSEd(ORL) (1)  ·  Nyree Penn, MHSc., CAA, Master of Health Science (1)

Results publications

PMID 35748777, PMID 40802194

NIH funding

2017 (1)